These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20156209)

  • 21. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy during the use of levonorgestrel intrauterine system.
    Backman T; Rauramo I; Huhtala S; Koskenvuo M
    Am J Obstet Gynecol; 2004 Jan; 190(1):50-4. PubMed ID: 14749634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection and performance of the levonorgestrel-releasing intrauterine system.
    Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
    Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland.
    Backman T; Huhtala S; Tuominen J; Luoto R; Erkkola R; Blom T; Rauramo I; Koskenvuo M
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():23-6. PubMed ID: 11336430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of the levonorgestrel-releasing intrauterine system in perimenopausal women with menorrhagia or dysmenorrhea.
    Yoo HJ; Lee MA; Ko YB; Yang JB; Kang BH; Lee KH
    Arch Gynecol Obstet; 2012 Jan; 285(1):161-6. PubMed ID: 21671063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
    Römer T; Linsberger D
    Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M; Odlind V
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up.
    Hurskainen R; Teperi J; Rissanen P; Aalto AM; Grenman S; Kivelä A; Kujansuu E; Vuorma S; Yliskoski M; Paavonen J
    JAMA; 2004 Mar; 291(12):1456-63. PubMed ID: 15039412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
    Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
    Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing drug-resistant essential menorrhagia without hysterectomy.
    Hurskainen R
    Best Pract Res Clin Obstet Gynaecol; 2006 Oct; 20(5):681-94. PubMed ID: 16731045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of menorrhagia with an LNG-IUS.
    Pakarinen P; Luukkainen T
    Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
    Andrade A; Wildemeersch D
    Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.
    Hurskainen R; Teperi J; Rissanen P; Aalto AM; Grenman S; Kivelä A; Kujansuu E; Vuorma S; Yliskoski M; Paavonen J
    Lancet; 2001 Jan; 357(9252):273-7. PubMed ID: 11214131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
    Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
    Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users.
    Gorgen H; Api M; Akça A; Cetin A
    Arch Gynecol Obstet; 2009 Jun; 279(6):835-40. PubMed ID: 19018547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction.
    Lete I; Obispo C; Izaguirre F; Orte T; Rivero B; Cornellana MJ; Bermejo I;
    Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):231-7. PubMed ID: 18609346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.